Antiviral to treat COVID-19 will soon arrive in the Czech Republic. Photo credit: Freepik
Prague, Aug 23 (CTK) – The Czech Ministry of Health has signed a contract with the American pharmaceutical company Pfizer for the supply of the antiviral drug Paxlovid used for the treatment of COVID-19 until the end of this year. The first delivery is due to arrive in the Czech Republic in September, ministry spokesman Ondrej Jakob told CT today.
The ministry cannot release the amount paid for the medicine due to the confidential terms of the contract, he added.
The ministry was originally looking to purchase 50,000 doses for CZK 1 billion.
“We will soon be able to offer another highly effective antiviral drug against COVID-19, fully covered by health insurance, to all Czech patients who need it. The pandemic is not over yet. COVID-19 is a deadly disease for which we must be prepared,” said Minister of Health Vlastimil Valek (TOP 09).
The Czech Ministry of Health has been negotiating a supply of Paxlovid since the beginning of this year. However, he refused to pay for the pre-arranged number of pre-arranged doses which might not all be used.
“This contract allows us to order drugs as needed. Unused drugs will not have to be covered by the state budget, as has sometimes happened in the past, for example in the case of monoclonal antibodies,” Jakob said.
The Czech Republic also had unused COVID vaccines that it was trying to donate to developing countries, but some of them had to be disposed of because their use-by date had expired.
Due to long negotiations, Paxlovid will be available in the Czech Republic later than in neighboring countries. In neighboring Slovakia, doctors can prescribe it since early August.
With Paxlovid, Pfizer produces the Comirnaty vaccine against COVID-19. More than 14.8 million doses of this vaccine have been applied in the Czech Republic, representing almost 83% of all vaccine doses administered.
In the past, monoclonal antibodies were given to COVID patients at high risk for severe disease progression, but they are not as effective for the Omicron variant. Apart from antivirals, the Czech Republic already has Molnupiravir from the firm Merck Sharp & Dohme (MSD). Doctors are also administering Remdesivir, the first drug approved for COVID-19, to patients who are suitable for this treatment.
https://brnodaily.com/2022/08/23/news/first-shipment-of-paxlovid-covid-drug-to-arrive-in-czech-republic-in-september/https://brnodaily.com/wp-content/uploads/2021/03/female-women-doctors-healthcare-hospital-medicine-covid-coronavirus-credit-freepik-2-1024×681.jpghttps://brnodaily.com/wp-content/uploads/2021/03/female-women-doctors-healthcare-hospital-medicine-covid-coronavirus-credit-freepik-2-150×100.jpgCzech Republic / WorldCovid-19,Czech Republic,Drugs,HealthAntiviral to treat COVID-19 will soon arrive in the Czech Republic. Photo credit: Freepik Prague, August 23 (CTK) – The Czech Ministry of Health has signed a contract with the American pharmaceutical company Pfizer for the supply of the antiviral drug Paxlovid used for the treatment of COVID-19 until the end of …Czech News AgencyCzech
Press Agency[email protected]AuthorBrno Daily